BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7784057)

  • 1. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
    Lukas J; Bartkova J; Welcker M; Petersen OW; Peters G; Strauss M; Bartek J
    Oncogene; 1995 Jun; 10(11):2125-34. PubMed ID: 7784057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
    Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
    Lukas J; Pagano M; Staskova Z; Draetta G; Bartek J
    Oncogene; 1994 Mar; 9(3):707-18. PubMed ID: 8108113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
    Bartkova J; Lukas J; Strauss M; Bartek J
    Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
    Lukas J; Jadayel D; Bartkova J; Nacheva E; Dyer MJ; Strauss M; Bartek J
    Oncogene; 1994 Aug; 9(8):2159-67. PubMed ID: 8036001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
    Lukas J; Aagaard L; Strauss M; Bartek J
    Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Further study on cyclin D1 expression and function in human nasopharyngeal carcinoma cell line].
    Zhao X; Deng L; Weng X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):373-5. PubMed ID: 11810764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
    Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
    J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
    Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
    Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
    Vaziri C; Stice L; Faller DV
    Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D; Sun W; Paik SK; Lee CC; Kim K
    Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to mammalian D-type G1 cyclins.
    Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
    Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
    Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
    Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.